Industries
Showing 31–40 of 134 results
-
IOL (Intra-Ocular Lens) Replacement in Private Healthcare Institutions Market in Hong Kong
USD 10According to StrategyHelix, the IOL (intra-ocular lens) replacement in private healthcare institutions market in Hong Kong is expected to increase at a CAGR of 8.3% till 2027.
-
Laser-Assisted in situ Keratomileusis (LASIK) in Private Healthcare Institutions Market in Hong Kong
USD 5According to a statistic by StrategyHelix, the laser-assisted in situ keratomileusis (LASIK) in private healthcare institutions market in Hong Kong is set to fall at CAGR of -13.3% in the next five years.
-
Small Incision Lenticule Extraction (SMILE) in Private Healthcare Institutions Market in Hong Kong
USD 5The small incision lenticule extraction (SMILE) in private healthcare institutions market in Hong Kong is projected to expand by a CAGR of 19.6% from 2021 through 2027, according to data and analytics company StrategyHelix.
-
Ophthalmic Healthcare Service Market in Hong Kong
USD 10A statistic by StrategyHelix indicates that the ophthalmic healthcare service market in Hong Kong is expected to increase by US$ 422 million from 2021 to 2027, garnering a CAGR of 5.3% during the forecast period.
-
Quadrivalent Influenza Vaccine Market in China
USD 5The quadrivalent influenza vaccine market in China is set to increase by US$ 2,512 million from 2021 to 2027, representing a compound annual growth rate (CAGR) of 20.9% during the forecast period.
-
Shingles Vaccine Market in China
USD 5The shingles vaccine market in China is poised to grow by US$ 5,886 million from 2021 to 2027, registering a CAGR of 49.2% during the forecast period, according to StrategyHelix.
-
HPV Vaccine Market in China
USD 10The HPV vaccine market in China is poised to grow by US$ 5,054 million from 2021 to 2027, registering a CAGR of 18.7% during the forecast period, according to StrategyHelix.
-
Vaccine Market in China
USD 10According to StrategyHelix, the vaccine market in China is expected to increase by US$ 2,663 million during 2021-2027, expanding at a CAGR of 7.7% during the forecast period.
-
Global PD-1 (PD-L1) Therapy Market
USD 5According to a statistic by StrategyHelix, the global PD-1 (PD-L1) therapy market is poised to grow at a CAGR of around 16.3% over the analysis period of 2021 to 2027.
-
PD-1 (PD-L1) Therapy Market in China
USD 5The PD-1 (PD-L1) therapy market in China is poised to grow by US$ 4,330 million during 2021-2027, progressing at a CAGR of 12.3% during the forecast period, according to data and analytics company StrategyHelix.
